Miroslav Vaštík

Tau protein, beta-amyloid1–42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia

Hana Přikrylová Vranová, Eva Hényková, Michaela Kaiserová et al. · Journal of the Neurological Sciences · 2014 · 56 citations

Medicine, Neurology, Neuroscience +17

Clusterin CSF levels in differential diagnosis of neurodegenerative disorders

Hana Přikrylová Vranová, Eva Hényková, Jan Mareš et al. · Journal of the Neurological Sciences · 2015 · 35 citations

Life Sciences, Neurology, Neuroscience +12

Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease

Sandra Kurčová, Jan Bardoň, Miroslav Vaštík et al. · Medicine · 2018 · 31 citations · Full text

Medicine, Neurology, Neuroscience +17

Treatment of camptocormia with continuous subcutaneous infusions of apomorphine: 1-year prospective pilot study

Kateřina Menšíková, Michaela Kaiserová, Miroslav Vaštík et al. · Journal of Neural Transmission · 2014 · 17 citations

Medicine, Pharmacology, Pharmacotherapy +4

Peripheral neuropathy in Parkinson's disease.

Zuzana Grambalova, Michaela Kaiserová, Miroslav Vaštík et al. · PubMed · 2015 · 17 citations

Medicine, Neurology, Neuroscience +17